Updates from The Motley Fool

Latest updates on Amgen from Fool.com.


Stock Performance

AMGN vs. S&P 500 | 2 Year Performance
AMGN 1-Day Stock Chart
AMGN 5-Day Stock Chart
AMGN 1-Month Stock Chart
AMGN 3-Month Stock Chart
AMGN 6-Month Stock Chart
AMGN 1-Year Stock Chart
AMGN 2-Year Stock Chart
AMGN 5-Year Stock Chart
View Interactive AMGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Amgen.
Current Price: $158.30
Prev Close: $160.56
Open: $159.39
Bid: $157.01
Ask: $158.30
Day's Range: $156.38 - $161.92
52wk Range: $130.09 - $181.81
Volume: 5,386,340
Avg Vol 3,024,014
Market Cap: $119.41B
P/E (ttm): 17.72
EPS (ttm): $9.06
Div & Yield: $4.00 (2.5%)

Company Rating

What our community thinks about Amgen.
CAPS Rating 4 out of 5
 
2165 Outperform
165 Underperform
CAPS All Stars
 
597 Outperform
22 Underperform

How do you think Amgen will perform against the market?



You pick for Amgen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert A. Bradway, CEO

53% Approve

Based on 354 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Amgen.

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers